Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial von MIDGLEY, Rachel S, MCCONKEY, Christopher C, LANGMAN, Michael J, KERR, David J, JOHNSTONE, Elaine C, DUNN, Janet A, SMITH, Justine L, GRUMETT, Simon A, JULIER, Patrick, IVESON, Claire, YANAGISAWA, Yoko, WARREN, Bryan

Volltext

Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer von Kerr, David J, Dunn, Janet A, Langman, Michael J, Smith, Justine L, Midgley, Rachel S.J, Stanley, Andrew, Stokes, Joanne C, Julier, Patrick, Iveson, Claire, Duvvuri, Ravi, McConkey, Christopher C

Volltext

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phas... von Waddell, Tom, MBBCh, Chau, Ian, MD, Cunningham, David, Prof, Gonzalez, David, PhD, Okines, Alicia Frances Clare, MBBCh, Wotherspoon, Andrew, MBBCh, Saffery, Claire, Middleton, Gary, MD, Wadsley, Jonathan, MBBCh, Ferry, David, Prof, Mansoor, Wasat, PhD, Crosby, Tom, MBBS, Coxon, Fareeda, MBBS, Smith, David, MD, Waters, Justin, PhD, Iveson, Timothy, MD, Falk, Stephen, MD, Slater, Sarah, MD, Peckitt, Clare, MSc, Barbachano, Yolanda, PhD

Volltext

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial von Iveson, Timothy J, Kerr, Rachel S, Saunders, Mark P, Cassidy, Jim, Hollander, Niels Henrik, Tabernero, Josep, Haydon, Andrew, Glimelius, Bengt, Harkin, Andrea, Allan, Karen, McQueen, John, Scudder, Claire, Boyd, Kathleen Anne, Briggs, Andrew, Waterston, Ashita, Medley, Louise, Wilson, Charles, Ellis, Richard, Essapen, Sharadah, Dhadda, Amandeep S, Harrison, Mark, Falk, Stephen, Raouf, Sherif, Rees, Charlotte, Olesen, Rene K, Propper, David, Bridgewater, John, Azzabi, Ashraf, Farrugia, David, Webb, Andrew, Cunningham, David, Hickish, Tamas, Weaver, Andrew, Gollins, Simon, Wasan, Harpreet S, Paul, James

Volltext

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial von Lamarca, Angela, Palmer, Daniel H, Wasan, Harpreet Singh, Ross, Paul J, Ma, Yuk Ting, Arora, Arvind, Falk, Stephen, Gillmore, Roopinder, Wadsley, Jonathan, Patel, Kinnari, Anthoney, Alan, Maraveyas, Anthony, Iveson, Tim, Waters, Justin S, Hobbs, Claire, Barber, Safia, Ryder, W David, Ramage, John, Davies, Linda M, Bridgewater, John A, Valle, Juan W

Volltext

Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study von Wagner, Sophia J., Reisenbüchler, Daniel, West, Nicholas P., Niehues, Jan Moritz, Zhu, Jiefu, Foersch, Sebastian, Veldhuizen, Gregory Patrick, Quirke, Philip, Grabsch, Heike I., van den Brandt, Piet A., Hutchins, Gordon G.A., Richman, Susan D., Yuan, Tanwei, Langer, Rupert, Jenniskens, Josien C.A., Offermans, Kelly, Mueller, Wolfram, Gray, Richard, Gruber, Stephen B., Greenson, Joel K., Rennert, Gad, Bonner, Joseph D., Schmolze, Daniel, Jonnagaddala, Jitendra, Hawkins, Nicholas J., Ward, Robyn L., Morton, Dion, Seymour, Matthew, Magill, Laura, Nowak, Marta, Hay, Jennifer, Koelzer, Viktor H., Church, David N., Church, David, Domingo, Enric, Edwards, Joanne, Glimelius, Bengt, Gogenur, Ismail, Harkin, Andrea, Hay, Jen, Iveson, Timothy, Jaeger, Emma, Kelly, Caroline, Kerr, Rachel, Maka, Noori, Morgan, Hannah, Oien, Karin, Orange, Clare, Palles, Claire, Roxburgh, Campbell, Sansom, Owen, Saunders, Mark, Tomlinson, Ian, Matek, Christian, Geppert, Carol, Peng, Chaolong, Zhi, Cheng, Ouyang, Xiaoming, James, Jacqueline A., Loughrey, Maurice B., Salto-Tellez, Manuel, Brenner, Hermann, Hoffmeister, Michael, Truhn, Daniel, Schnabel, Julia A., Boxberg, Melanie, Peng, Tingying, Kather, Jakob Nikolas

Volltext

Artificial intelligence for dementia—Applied models and digital health von Lyall, Donald M., Kormilitzin, Andrey, Lancaster, Claire, Sousa, Jose, Petermann‐Rocha, Fanny, Buckley, Christopher, Harshfield, Eric L., Iveson, Matthew H., Madan, Christopher R., McArdle, Ríona, Newby, Danielle, Orgeta, Vasiliki, Tang, Eugene, Tamburin, Stefano, Thakur, Lokendra S., Lourida, Ilianna, Llewellyn, David J., Ranson, Janice M.

Volltext

Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II–III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis von Frei, Anja L, McGuigan, Anthony, Sinha, Ritik R A K, Jabbar, Faiz, Gneo, Luciana, Tomasevic, Tijana, Harkin, Andrea, Iveson, Tim, Saunders, Mark P, Oien, Karin A, Maka, Noori, Pezzella, Francesco, Campo, Leticia, Browne, Molly, Glaire, Mark, Kildal, Wanja, Danielsen, Havard E, Hay, Jennifer, Edwards, Joanne, Sansom, Owen, Kelly, Caroline, Tomlinson, Ian, Kerr, Rachel, Kerr, David, Domingo, Enric, Church, David N, Domingo, Enric, Edwards, Joanne, Glimelius, Bengt, Gonegur, Ismail, Harkin, Andrea, Hay, Jen, Iveson, Timothy, Jaeger, Emma, Kelly, Caroline, Kerr, Rachel, Maka, Noori, Morgan, Hannah, Oien, Karen, Orange, Clare, Palles, Claire, Roxburgh, Campbell, Sansom, Owen, Saunders, Mark P, Tomlinson, Ian, Church, David N, Koelzer, Viktor H

Volltext

Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials von Gallois, Claire, Shi, Qian, Meyers, Jeffrey P, Iveson, Timothy, Alberts, Steven R, de Gramont, Aimery, Sobrero, Alberto F, Haller, Daniel G, Oki, Eiji, Shields, Anthony Frank, Goldberg, Richard M, Kerr, Rachel, Lonardi, Sara, Yothers, Greg, Kelly, Caroline, Boukovinas, Ioannis, Labianca, Roberto, Sinicrope, Frank A, Souglakos, Ioannis, Yoshino, Takayuki, Meyerhardt, Jeffrey A, André, Thierry, Papamichael, Demetris, Taieb, Julien

Volltext

Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts von Taieb, Julien, Basile, Debora, Seligmann, Jenny, Argiles, Guillem, André, Thierry, Gallois, Claire, Goldberg, Richard M., Yothers, Greg, Sobrero, Alberto, Meyerhardt, Jeffrey A., Souglakos, John, Labianca, Roberto, Iveson, Tim, Church, David N., Arnold, Dirk, Tie, Jeanne, Gill, Sharlene, Laurent-Puig, Pierre, Yoshino, Takayuki, Lonardi, Sara, Shi, Qian

Volltext

Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia von Du, Houwei, Wilson, Duncan, Ambler, Gareth, Banerjee, Gargi, Shakeshaft, Clare, Cohen, Hannah, Yousry, Tarek, Al-Shahi Salman, Rustam, Lip, Gregory Y.H., Houlden, Henry, Brown, Martin M., Muir, Keith W., Jäger, Hans Rolf, Werring, David J.

Volltext

A novel genetic marker of fluoropyrimidine-induced cardiovascular toxicity von Palles, Claire, Lucas, Marie, Watts, Katie, Galavotti, Sara, Chin, Ik Shin, Campbell, Cameron, Briggs, Sarah E W, Jaeger, Emma, Church, David, Taylor, Karen, Bliss, Judith, Fisher, David, Madi, Ayman, Cameron, David A., Maughan, Timothy S., Tomlinson, Ian, Iveson, Timothy, Kerr, David James, Kerr, Rachel, Cheadle, Jeremy

Volltext

Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage von Best, Jonathan G., Barbato, Carmen, Ambler, Gareth, Du, Houwei, Banerjee, Gargi, Wilson, Duncan, Shakeshaft, Clare, Cohen, Hannah, Yousry, Tarek A., Al-Shahi Salman, Rustam, Lip, Gregory Y.H., Houlden, Henry, Brown, Martin M., Muir, Keith W., Jäger, Hans Rolf, Werring, David J., Adrian, Parry Jones, Patterson, Chris, Price, Christopher, Elmarimi, Abduelbaset, Parry, Anthea, Nallasivam, Arumug, Mohd Nor, Azlisham, Esis, Bernard, Nascimento, Fabio, Bruce, David, Bhaskaran, Biju, Roffe, Christine, Cullen, Claire, Holmes, Clare, Cohen, David, Hargroves, David, Mangion, David, Chadha, Dinesh, Vahidassr, Djamil, Manawadu, Dulka, Giallombardo, Elio, Warburton, Elizabeth, Flossman, Enrico, Gunathilagan, Gunaratam, Proschel, Harald, Emsley, Hedley, Anwar, Ijaz, Burger, Ilse, Okwera, James, Putterill, Janet, O'Connell, Janice, Bamford, John, Corrigan, John, Scott, Jon, Birns, Jonathan, Kee, Karen, Saastamoinen, Kari, Pasco, Kath, Dani, Krishna, Sekaran, Lakshmanan, Choy, Lillian, Iveson, Liz, Mamun, Maam, Sajid, Mahmud, Cooper, Martin, Burn, Matthew, Smith, Matthew, Power, Michael, Davis, Michelle, Smyth, Nigel, Veltkamp, Roland, Sharma, Pankaj, Guyler, Paul, O'Mahony, Paul, Wilkinson, Peter, Datta, Prabel, Aghoram, Prasanna, Marsh, Rachel, Luder, Robert, Meenakishundaram, Sanjeevikumar, Subramonian, Santhosh, Leach, Simon, Ispoglou, Sissi, Andole, Sreeman, England, Timothy, Manoj, Aravindakshan, Harrington, Frances, Rehman, Habiba, Sword, Jane, Staals, Julie, Mahawish, Karim, Harkness, Kirsty, Shaw, Louise, McCormich, Michael, Sprigg, Nikola, Mansoor, Syed, Krishnamurthy, Vinodh

Volltext

Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer von Nowak, Marta, Jabbar, Faiz, Rodewald, Ann-Katrin, Gneo, Luciana, Tomasevic, Tijana, Harkin, Andrea, Iveson, Tim, Saunders, Mark, Kerr, Rachel, Oein, Karin, Maka, Noori, Hay, Jennifer, Edwards, Joanne, Tomlinson, Ian, Sansom, Owen, Kelly, Caroline, Pezzella, Francesco, Kerr, David, Easton, Alistair, Domingo, Enric, Glimelius, Bengt, Gogenur, Ismail, Jaeger, Emma, Morgan, Hannah, Orange, Clare, Palles, Claire, Roxburgh, Campbell, Koelzer, Viktor H., Church, David N.

Volltext

Prognostic impact of early treatment discontinuation and early oxaliplatin discontinuation in patients treated with 6 months of oxaliplatin-based adjuvant chemotherapy for stage II... von Gallois, Claire, Shi, Qian, Meyers, Jeffrey P., Iveson, Timothy, Alberts, Steven R, De Gramont, Aimery, Sobrero, Alberto F., Haller, Daniel G., Oki, Eiji, Shields, Anthony Frank, Kelly, Caroline, Boukovinas, Ioannis, Labianca, Roberto, Sinicrope, Frank A., Sougklakos, Ioannis, Yoshino, Takayuki, Meyerhardt, Jeffrey A., Andre, Thierry, Papamichail, Demetris, Taieb, Julien

Volltext

Second-line FOLFOX chemotherapy for advanced biliary tract cancer von Lamarca, Angela, Palmer, Daniel H., Wasan, Harpreet Singh, Ross, Paul J., Ma, Yuk Ting, Arora, Arvind, Falk, Stephen, Gillmore, Roopinder, Wadsley, Jonathan, Patel, Kinnari, Anthoney, Alan, Maraveyas, Anthony, Iveson, Tim, Waters, Justin S., Hobbs, Claire, Barber, Safia, David Ryder, W., Ramage, John, Davies, Linda M., Bridgewater, John A., Valle, Juan W.

Volltext

Second-line FOLFOX chemotherapy for advanced biliary tract cancer – Authors' reply von Lamarca, Angela, Palmer, Daniel H, Wasan, Harpreet Singh, Ross, Paul J, Ma, Yuk Ting, Arora, Arvind, Falk, Stephen, Gillmore, Roopinder, Wadsley, Jonathan, Patel, Kinnari, Anthoney, Alan, Maraveyas, Anthony, Iveson, Tim, Waters, Justin S, Hobbs, Claire, Barber, Safia, Ryder, W David, Ramage, John, Davies, Linda M, Bridgewater, John A, Valle, Juan W

Volltext

Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer von Gray, Victoria, Briggs, Sarah, Palles, Claire, Jaeger, Emma, Iveson, Timothy, Kerr, Rachel, Saunders, Mark P, Paul, James, Harkin, Andrea, McQueen, John, Summers, Matthew G, Johnstone, Elaine, Wang, Haitao, Gatcombe, Laura, Maughan, Timothy S, Kaplan, Richard, Escott-Price, Valentina, Al-Tassan, Nada A, Meyer, Brian F, Wakil, Salma M, Houlston, Richard S, Cheadle, Jeremy P, Tomlinson, Ian, Church, David N

Volltext

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial von Iveson, Timothy J, Kerr, Rachel S, Saunders, Mark P, Cassidy, Jim, Hollander, Niels Henrik, Tabernero, Josep, Haydon, Andrew, Glimelius, Bengt, Harkin, Andrea, Allan, Karen, McQueen, John, Scudder, Claire, Boyd, Kathleen Anne, Briggs, Andrew, Waterston, Ashita, Medley, Louise, Wilson, Charles, Ellis, Richard, Essapen, Sharadah, Dhadda, Amandeep S, Harrison, Mark, Falk, Stephen, Raouf, Sherif, Rees, Charlotte, Olesen, Rene K, Propper, David, Bridgewater, John, Azzabi, Ashraf, Farrugia, David, Webb, Andrew, Cunningham, David, Hickish, Tamas, Weaver, Andrew, Gollins, Simon, Wasan, Harpreet S, Paul, James

Volltext

Final DFS results of the SCOT study: An international phase III randomised (1:1) non-inferiority trial comparing 3 versus 6 months of oxaliplatin based adjuvant chemotherapy for co... von Iveson, Timothy, Kerr, Rachel, Saunders, Mark P., Hollander, Niels Henrik, Tabernero, Josep, Haydon, Andrew Mark, Glimelius, Bengt, Harkin, Andrea, Scudder, Claire, Boyd, Kathleen, Waterston, Ashita Marie, Medley, Louise C., Wilson, Charles, Ellis, Richard, Essapen, Sharadah, Dhadda, Amandeep Singh, Harrison, Mark, Falk, Stephen, Raouf, Sherif, Paul, James

Volltext